In which case pneumococcal vaccine is most effective:
**Core Concept**
The pneumococcal vaccine is a conjugate vaccine designed to protect against Streptococcus pneumoniae infections, which can cause pneumonia, meningitis, and sepsis. The vaccine is most effective in populations with high disease burden and limited access to healthcare.
**Why the Correct Answer is Right**
The pneumococcal vaccine is most effective in children under the age of 2 years, especially in developing countries where access to healthcare is limited. This is because children in this age group are at highest risk of developing invasive pneumococcal disease (IPD), and the vaccine can significantly reduce the incidence of IPD and its associated mortality. The vaccine works by inducing immunity to the capsular polysaccharide of S. pneumoniae, which is essential for the bacteria's survival and virulence.
**Why Each Wrong Option is Incorrect**
**Option A:** This is incorrect because while pneumococcal vaccine is effective in older adults, it is not the most effective population. The vaccine is recommended for adults aged 65 years and older, but its effectiveness is lower compared to children under 2 years.
**Option B:** This is incorrect because pneumococcal vaccine is not most effective in healthy adults. While the vaccine is recommended for adults with certain underlying medical conditions, its effectiveness is not as high as in children under 2 years.
**Option C:** This is incorrect because pneumococcal vaccine is not most effective in individuals with HIV/AIDS. While the vaccine is recommended for individuals with HIV/AIDS, its effectiveness is lower due to the compromised immune system.
**Clinical Pearl / High-Yield Fact**
The pneumococcal conjugate vaccine is a crucial component of childhood immunization schedules in developing countries, where it can significantly reduce the burden of invasive pneumococcal disease and its associated mortality.
**Correct Answer:** C. Children under 2 years.